These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 22755485)

  • 1. Physical health of patients with severe mental illness: an intervention on medium secure forensic unit.
    Vasudev K; Thakkar PB; Mitcheson N
    Int J Health Care Qual Assur; 2012; 25(4):363-70. PubMed ID: 22755485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health behaviour beliefs and physical health risk factors for cardiovascular disease in an outpatient sample of consumers with a severe mental illness: a cross-sectional survey.
    Brunero S; Lamont S
    Int J Nurs Stud; 2010 Jun; 47(6):753-60. PubMed ID: 19959166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased cardiovascular risk in patients with severe mental illness.
    Gladigau EL; Fazio TN; Hannam JP; Dawson LM; Jones SG
    Intern Med J; 2014 Jan; 44(1):65-9. PubMed ID: 24383746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical factors related to gains in body mass index (BMI) among patients under long-term antipsychotic treatment].
    Koga M
    Seishin Shinkeigaku Zasshi; 2003; 105(4):473-88. PubMed ID: 12806910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bridging the gap between mental and physical health: a multidisciplinary approach.
    Vreeland B
    J Clin Psychiatry; 2007; 68 Suppl 4():26-33. PubMed ID: 17539697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does training practice nurses to carry out physical health checks for people with severe mental illness increase the level of screening for cardiovascular risk?
    Hardy S; Hinks P; Gray R
    Int J Soc Psychiatry; 2014 May; 60(3):236-42. PubMed ID: 23608954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipid balance and cardiovascular risk in patients in a psychiatric long-term facility].
    Berg JE; Wisløff S; Høstmark AT
    Tidsskr Nor Laegeforen; 2004 Oct; 124(20):2615-7. PubMed ID: 15534634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome and mental illness.
    Newcomer JW
    Am J Manag Care; 2007 Nov; 13(7 Suppl):S170-7. PubMed ID: 18041878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical health monitoring of patients with schizophrenia.
    Marder SR; Essock SM; Miller AL; Buchanan RW; Casey DE; Davis JM; Kane JM; Lieberman JA; Schooler NR; Covell N; Stroup S; Weissman EM; Wirshing DA; Hall CS; Pogach L; Pi-Sunyer X; Bigger JT; Friedman A; Kleinberg D; Yevich SJ; Davis B; Shon S
    Am J Psychiatry; 2004 Aug; 161(8):1334-49. PubMed ID: 15285957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
    Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
    Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment decisions in major mental illness: weighing the outcomes.
    Vreeland B
    J Clin Psychiatry; 2007; 68 Suppl 12():5-11. PubMed ID: 17956150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia.
    Barnett AH; Mackin P; Chaudhry I; Farooqi A; Gadsby R; Heald A; Hill J; Millar H; Peveler R; Rees A; Singh V; Taylor D; Vora J; Jones PB
    J Psychopharmacol; 2007 Jun; 21(4):357-73. PubMed ID: 17656425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the safety and efficacy of atypical antipsychotics in psychiatric patients with comorbid medical illnesses.
    Newcomer JW
    J Clin Psychiatry; 2009; 70 Suppl 3():30-6. PubMed ID: 19570499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of monitoring and management guidelines for second-generation antipsychotics.
    Sernyak MJ
    J Clin Psychiatry; 2007; 68 Suppl 4():14-8. PubMed ID: 17539695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considering a frame of reference for physical activity research related to the cardiometabolic risk profile in schizophrenia.
    Vancampfort D; Knapen J; Probst M; van Winkel R; Deckx S; Maurissen K; Peuskens J; De Hert M
    Psychiatry Res; 2010 May; 177(3):271-9. PubMed ID: 20406713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic impact of switching antipsychotic therapy to aripiprazole after weight gain: a pilot study.
    Kim SH; Ivanova O; Abbasi FA; Lamendola CA; Reaven GM; Glick ID
    J Clin Psychopharmacol; 2007 Aug; 27(4):365-8. PubMed ID: 17632220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schizophrenia, obesity, and antipsychotic medications: what can we do?
    Citrome L; Vreeland B
    Postgrad Med; 2008 Jul; 120(2):18-33. PubMed ID: 18654065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term health considerations in schizophrenia: metabolic effects and the role of abdominal adiposity.
    Van Gaal LF
    Eur Neuropsychopharmacol; 2006 Sep; 16 Suppl 3():S142-8. PubMed ID: 16863690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: a quality improvement programme.
    Barnes TR; Paton C; Hancock E; Cavanagh MR; Taylor D; Lelliott P;
    Acta Psychiatr Scand; 2008 Jul; 118(1):26-33. PubMed ID: 18582345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.